BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4217089)

  • 1. Studies on GM1-gangliosidosis, type II.
    Patel V; Goebel HH; Watanabe I; Zeman W
    Acta Neuropathol; 1974; 30(2):155-73. PubMed ID: 4217089
    [No Abstract]   [Full Text] [Related]  

  • 2. GM3 (hematoside) sphingolipodystrophy.
    Max SR; Maclaren NK; Brady RO; Bradley RM; Rennels MB; Tanaka J; Garcia JH; Cornblath M
    N Engl J Med; 1974 Oct; 291(18):929-31. PubMed ID: 4213132
    [No Abstract]   [Full Text] [Related]  

  • 3. Juvenile GM1 gangliosidosis. Occurrence with absence of two beta-galactosidase components.
    Lowden JA; Callahan JW; Norman MG; Thain M; Prichard JS
    Arch Neurol; 1974 Sep; 31(3):200-3. PubMed ID: 4368854
    [No Abstract]   [Full Text] [Related]  

  • 4. GM1-gangliosidosis without chondrodystrophy or visceromegaly. B-galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate.
    Wolfe LS; Callahan J; Fawcett JS; Andermann F; Scriver CR
    Neurology; 1970 Jan; 20(1):23-44. PubMed ID: 4243740
    [No Abstract]   [Full Text] [Related]  

  • 5. Tay-Sachs' retina. Deficiency of acetyl hexosaminidase A.
    Cotlier E
    Arch Ophthalmol; 1971 Sep; 86(3):352-6. PubMed ID: 5095559
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme histochemical and ultrastructural alterations in the brains of Friesian calves with GM1 gangliosidosis.
    Sheahan BJ; Donnelly WJ
    Acta Neuropathol; 1974; 30(1):73-84. PubMed ID: 4217088
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases.
    Tomasi LG; Fukushima DK; Kolodny EH
    Neurology; 1974 Dec; 24(12):1158-65. PubMed ID: 4280528
    [No Abstract]   [Full Text] [Related]  

  • 8. GM2 Type 2--gangliosidosis (Sandhoff's disease)--ocular and pathological manifestations.
    Tremblay M; Szots F
    Can J Ophthalmol; 1974 Jul; 9(3):338-46. PubMed ID: 4276769
    [No Abstract]   [Full Text] [Related]  

  • 9. An electrophoretic variant of beta-galactosidase with altered catalytic properties in a patient with GM1 gangliosidosis.
    Norden AG; O'Brien JS
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):240-4. PubMed ID: 804170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new variant of Sandhoff's disease.
    Spence MW; Ripley BA; Embil JA; Tibbles JA
    Pediatr Res; 1974 Jun; 8(6):628-37. PubMed ID: 4134664
    [No Abstract]   [Full Text] [Related]  

  • 11. GM1 gangliosidosis type II.
    Hooft C; Vlietinck RF; Dacremont G; Kint JA
    Eur Neurol; 1970; 4(1):1-21. PubMed ID: 5473215
    [No Abstract]   [Full Text] [Related]  

  • 12. A type of juvenile cerebromacular degeneration characterized by granular osmiophilic deposits.
    Carpenter S; Karpati G; Wolfe LS; Andermann F
    J Neurol Sci; 1973 Jan; 18(1):67-87. PubMed ID: 4120484
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinal pathology in GM 1 gangliosidosis, type II.
    Goebel HH; Fix JD; Zeman W
    Am J Ophthalmol; 1973 Mar; 75(3):434-41. PubMed ID: 4697195
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Synthetic defect in ganglioside metabolism.
    O'Brien JS
    N Engl J Med; 1974 Oct; 291(18):975-6. PubMed ID: 4213050
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile GM2 gangliosidosis. Biochemical and ultrastructural studies on a new variant of Tay-Sachs disease.
    Menkes JH; O'Brien JS; Okada S; Grippo J; Andrews JM; Cancilla PA
    Arch Neurol; 1971 Jul; 25(1):14-22. PubMed ID: 5146406
    [No Abstract]   [Full Text] [Related]  

  • 16. Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man.
    Farrell DF; Baker HJ; Herndon RM; Lindsey JR; McKhann GM
    J Neuropathol Exp Neurol; 1973 Jan; 32(1):1-18. PubMed ID: 4119597
    [No Abstract]   [Full Text] [Related]  

  • 17. I-cell disease: biochemical studies.
    Leroy JG; Ho MW; MacBrinn MC; Zielke K; Jacob J; O'Brien JS
    Pediatr Res; 1972 Oct; 6(10):752-7. PubMed ID: 4346288
    [No Abstract]   [Full Text] [Related]  

  • 18. Gm1-gangliosidosis and juvenile cerebral lipidosis. Clinical, histochemical, and chemical study.
    Patton VM; Dekaban AS
    Arch Neurol; 1971 Jun; 24(6):529-37. PubMed ID: 5089899
    [No Abstract]   [Full Text] [Related]  

  • 19. Localized beta-galactosidase deficiency. Occurrence in cerebellar ataxia with myoclonus epilepsy and macular cherry-red spot--a new variant of GM1-gangliosidosis?
    Yamamoto A; Adachi S; Kawamura S; Takahashi M; Kitani T
    Arch Intern Med; 1974 Oct; 134(4):627-34. PubMed ID: 4278184
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple system atrophies. A neuropathological and neurochemical study.
    Martin JJ; Van Dessel G; Lagrou A; De Barsy AM; Dierick W
    J Neurol Sci; 1974 Mar; 21(3):251-72. PubMed ID: 4361662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.